Wednesday, November 16, 2016

BRIEF-Genexine granted FDA orphan drug designation for GX-H9 in growth hormone deficiency

* Genexine granted FDA orphan drug designation for GX-H9 in

growth hormone deficiency

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)